Published January 1, 2017 | Version v1
Journal article Open

Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

  • 1. Eskisehir Osmangazi Univ, Fac Med, Dept Chest Dis, Lung & Pleural Canc Res & Clin Ctr, TR-26000 Eskisehir, Turkey
  • 2. Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, Chiba, Chiba 2608670, Japan
  • 3. Toho Univ, Sch Med, Dept Surg, Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan
  • 4. Eskisehir Osmangazi Univ, Fac Med, Dept Publ Hlth, Lung & Pleural Canc Res & Clin Ctr, TR-26000 Eskisehir, Turkey
  • 5. Toho Univ, Sch Med, Dept Clin Oncol, Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan
  • 6. Tokyo Womens Med Univ, Dept Pathol, Yachiyo Med Ctr, 477-96 Owadasinden, Yachiyo 2768524, Japan

Description

Background: We evaluated possible diagnostic and prognostic values of serum midkine in malignant pleural mesothelioma in comparison with those of serum mesothelin, a well-established diagnostic biomarker.

Files

bib-bb7a7cb3-a6ea-47ac-ba6f-f6e899d1185d.txt

Files (252 Bytes)

Name Size Download all
md5:bbd1131fc211ccf9f764311721d50ecb
252 Bytes Preview Download